As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

Is AI just hype or a game-changer? Delve into AI's contribution to oncology, from diagnostics to drug discovery and ...

Discover advances in epilepsy treatments, innovative solutions for seizure freedom, and challenges in integrating new ...

Discover Booster Therapeutics' novel 20S proteasome activation approach to neurodegenerative diseases as it launches with $15 ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

Discover visionary biotech entrepreneurs, nominated by VCs, who are revolutionizing the industry with innovative, ...

Biotech IPO activity in the US has spiked for the second time this year, following an initial boost in Q1 2024. Largely ...

Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the ...

Explore innovative treatments for spinal cord injury in clinical trials, including Lineage's OPC1 and NervGen's NVG-291, ...

Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and leading to ...

Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news sorted by top pharmaceutical companies and by month. We meticulously curate and categorize the latest ...